Horizon Kinetics’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Horizon Kinetics’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$7K	Hold	15,940	–	–	﹤0.01%	471
2018 Q3	$8K	Hold	15,940	–	–	﹤0.01%	503
2018 Q2	$8K	Hold	15,940	–	–	﹤0.01%	510
2018 Q1	$7K	Hold	15,940	–	–	﹤0.01%	508
2017 Q4	$6K	Hold	15,940	–	–	﹤0.01%	495
2017 Q3	$6K	Hold	15,940	–	–	﹤0.01%	492
2017 Q2	$6K	Hold	15,940	–	–	﹤0.01%	506
2017 Q1	$7K	Hold	15,940	–	–	﹤0.01%	501
2016 Q4	$6K	Hold	15,940	–	–	﹤0.01%	506
2016 Q3	$4K	Hold	15,940	–	–	﹤0.01%	507
2016 Q2	$4K	Hold	15,940	–	–	﹤0.01%	521
2016 Q1	$2K	Hold	15,940	–	–	﹤0.01%	530
2015 Q4	$2K	Hold	15,940	–	–	﹤0.01%	508
2015 Q3	$3K	Hold	15,940	–	–	﹤0.01%	504
2015 Q2	$11K	Hold	15,940	–	–	﹤0.01%	519
2015 Q1	$11K	Hold	15,940	–	–	﹤0.01%	521
2014 Q4	$13K	Hold	15,940	–	–	﹤0.01%	519
2014 Q3	$7K	Hold	15,940	–	–	﹤0.01%	520
2014 Q2	$8K	Hold	15,940	–	–	﹤0.01%	529
2014 Q1	$5K	Hold	15,940	–	–	﹤0.01%	533
2013 Q4	$5K	Hold	15,940	–	–	﹤0.01%	536
2013 Q3	$32K	Buy	15,940 +402	+3%	+$766	﹤0.01%	538
2013 Q2	$30K	Buy	+15,538	New	+$27.3K	﹤0.01%	460

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Horizon Kinetics's GCVRZ Position: Q4 2018 in Review

Horizon Kinetics held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q4 2018 at 15,940 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #471.

Horizon Kinetics first reported a position in GCVRZ in Q2 2013 and has held it in 23 quarters since. The position peaked at $32K in Q3 2013. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2018.

Horizon Kinetics held 15,940 shares of Sanofi Contingent Value Rights worth $7K as of Q4 2018.
Horizon Kinetics left its Sanofi Contingent Value Rights share count unchanged in Q4 2018.
Sanofi Contingent Value Rights made up ﹤0.01% of Horizon Kinetics's portfolio in Q4 2018, its #471 holding.
Horizon Kinetics first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 23 quarters since.
Horizon Kinetics's Sanofi Contingent Value Rights position peaked at $32K in Q3 2013.
103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.